NLR and PLR Levels Following iPACK Block in Hip Arthroplasty

Launched by POZNAN UNIVERSITY OF MEDICAL SCIENCES · Jun 8, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "NLR and PLR Levels Following iPACK Block in Hip Arthroplasty," is investigating how a specific type of pain management technique, called the PENG block, affects certain blood markers (NLR and PLR) after hip surgery. The trial will look at patients who are scheduled for hip replacement surgery and aims to gather information about how this procedure can help with pain relief and recovery.

To be eligible for the study, participants must be between 20 and 90 years old, have an ASA classification of I-III (which means they are generally healthy or have mild to moderate health issues), and must be having their surgery under spinal anesthesia. However, individuals with certain conditions, such as bleeding disorders, those taking blood thinners, or those with chronic pain prior to the surgery, will not be able to participate. If you join the trial, you can expect to receive the PENG block for pain relief during your hip surgery and will be monitored for how well it works. This study is not yet recruiting participants, but it aims to contribute valuable information to improve pain management in hip surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with ASA classification I-III
• • Aged 20-90 years
• • Who will be scheduled for hip arthroplasty under spinal anesthesia
• Exclusion Criteria:
• • Patients who have a history of bleeding diathesis
• • Take anticoagulant therapy
• • History of chronic pain before surgery
• • Multiple trauma
• • patients unable to assess their pain (dementia)
• • patients operated under general anesthesia
• • patients having an infection in the region of the procedure
• • the patient who does not accept the procedure